PIM kinase inhibitor TP-3654
Term · Oncology and biomedicine · MLC-T-ONC-016072
An orally available, second-generation and selective ATP-competitive inhibitor of proviral integration site for Moloney murine leukemia virus (PIM) kinases, with potential antineoplastic activity. Upon oral administration, PIM kinase inhibitor TP-3654 selectively binds to and prevents the activation of the PIM kinases. This prevents the activation of PIM-mediated signaling pathways and inhibits proliferation in cells that overexpress PIM. PIMs, constitutively active proto-oncogenic serine/threonine kinases, are upregulated in various types of cancers and play key roles in tumor cell proliferation and survival.
| Identifier | MLC-T-ONC-016072 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | PIM inhibitor TP-3654 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016072",
"term": "PIM kinase inhibitor TP-3654",
"field": "Oncology and biomedicine",
"definition": "An orally available, second-generation and selective ATP-competitive inhibitor of proviral integration site for Moloney murine leukemia virus (PIM) kinases, with potential antineoplastic activity. Upon oral administration, PIM kinase inhibitor TP-3654 selectively binds to and prevents the activation of the PIM kinases. This prevents the activation of PIM-mediated signaling pathways and inhibits proliferation in cells that overexpress PIM. PIMs, constitutively active proto-oncogenic serine/threonine kinases, are upregulated in various types of cancers and play key roles in tumor cell proliferation and survival.",
"synonyms": [
"PIM inhibitor TP-3654"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pim-kinase-inhibitor-tp-3654/"
}
Record 13,245 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.